m+Medelevator.RU
← Поиск публикаций
Cureus · 2025

Evaluation of the Protective Effects of Moringa oleifera, Zingiber officinale, and Allium sativum in a Rat Model of Chronic Kidney Disease (CKD).

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Jalgaonkar Manjiri P, Bale Rajeshwari K, Singh Alok D, Doshi Gaurav M, Raheja Radhika K, Kulkarni Yogesh A, Oza Manisha J

Аннотация

BACKGROUND: Oxidative stress plays a key role in the development and progression of chronic kidney disease (CKD). In this study, it has been hypothesized that the extract of Moringa oleifera leaves, Zingiber officinale rhizomes, and Allium sativum cloves together might exert a protective effect against adenine-induced CKD in rats.

METHODS: Rats were randomly divided into five groups: Group 1: normal control; Group 2: disease control; Group 3: CKD + polyherbal extract (250 mg/kg); Group 4: CKD + polyherbal extract (500 mg/kg); Group 5: CKD + polyherbal extract (1500 mg/kg). CKD was induced by feeding rats a 0.3% adenine-mixed diet for 28 days. Polyherbal extract was administered to rats, except for Groups 1 and 2, for 28 days.

RESULTS: Experimental animals receiving treatment with polyherbal extract showed significant improvement in water intake (p< 0.001), urine volume (p< 0.01), urine creatinine (p < 0.05), plasma creatinine (p < 0.01), and blood urea nitrogen(p<0.05). Furthermore, the combined extract showed a potential effect in reducing oxidative stress and fibrosis, indicated by reduced hypertrophy in kidney tissue.

CONCLUSION: Polyherbal extract containing Moringa oleifera leaves, Zingiber officinale rhizomes, and Allium sativum clove extracts showed a reduction in fibrosis and oxidative stress, and thus, this polyherbal extract combination could be explored in-depth for its therapeutic potential in CKD.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты